ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 852 filers reported holding ISHARES TR in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,531 | -3.7% | 127 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $16,124 | -1.7% | 127 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $16,403 | -47.3% | 127 | -46.4% | 0.00% | -42.9% |
| Q4 2022 | $31,116 | +107.4% | 237 | +86.6% | 0.01% | 0.0% |
| Q3 2022 | $15,000 | 0.0% | 127 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $15,000 | -11.8% | 127 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $17,000 | -10.5% | 127 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $19,000 | -9.5% | 127 | 0.0% | 0.01% | -41.7% |
| Q3 2021 | $21,000 | 0.0% | 127 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $21,000 | +10.5% | 127 | 0.0% | 0.01% | +9.1% |
| Q1 2021 | $19,000 | +280.0% | 127 | +273.5% | 0.01% | +175.0% |
| Q3 2020 | $5,000 | +150.0% | 34 | +70.0% | 0.00% | +300.0% |
| Q2 2019 | $2,000 | -94.1% | 20 | -94.3% | 0.00% | -92.9% |
| Q4 2018 | $34,000 | -24.4% | 350 | -4.6% | 0.01% | -44.0% |
| Q3 2018 | $45,000 | +12.5% | 367 | 0.0% | 0.02% | +4.2% |
| Q2 2018 | $40,000 | -37.5% | 367 | -38.8% | 0.02% | -17.2% |
| Q4 2017 | $64,000 | – | 600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |